Skip to main content
. 2024 Apr 9;14:8271. doi: 10.1038/s41598-024-59026-2

Table 3.

Primary outcomes per PSI-class.

Oral (n = 71) Intravenous (n = 102)
Mortality, n (%)
 PSI III 0/22 (0.0) 0/26 (0.0)
 PSI IV 3/44 (6.8) 6/62 (9.7)
 PSI V 1/5 (20.0) 2/14 (14.3)
ICU-admission, n (%)
 PSI III 0/22 (0.0) 1/26 (3.8)
 PSI IV 1/44 (2.3) 5/62 (8.1)
 PSI V 0/5 (0.0) 0/14 (0.0)
Readmission within 7 days, n (%)
 PSI III 1/22 (4.5) 2/26 (7.7)
 PSI IV 3/44 (6.8) 7/62 (11.3)
 PSI V 0/5 (0.0) 0/14 (0.0)
Length of stay (days), median [IQR]
 PSI III 1 [0–2.8] 3 [2–4.8]
 PSI IV 2 [0–5] 4 [3–7]
 PSI V 2.5 [0.8–5] 4.5 [2.8–7]
Length of stay (days)a, median [IQR]
 PSI III 2 [1–4] 3 [2–4.8]
 PSI IV 3 [2–6] 4 [3–7]
 PSI V 4 [2.5–6] 4.5 [2.8–7]
Length of antibiotic treatment (days), median [IQR]
 PSI III 7 [5–7] 6.5 [6–7.8]
 PSI IV 7 [5–8] 7 [5–9]
 PSI V 7 [5–7] 6 [5.3–8]

ICU intensive care unit, IQR interquartile range, PSI pneumonia severity index. aOnly hospitalised patients.